Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Mark, Peter J ^a   Wyrwoll, Caitlin S ^a   Zulkafli, Intan S ^a   Mori, Trevor A ^b   Waddell, Brendan J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; DEXAMETHASONE; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; TRICHLORMETHINE; TUMOR NECROSIS FACTOR ALPHA; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; AUTACOID; DEXAMETHASONE ACETATE; GLUCOCORTICOID RECEPTOR; NR3C1 PROTEIN, RAT;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CYTOKINE RELEASE; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FEMALE; FETUS; INFLAMMATION; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NONHUMAN; PHENOTYPE; PRENATAL DRUG EXPOSURE; PROTEIN EXPRESSION; RAT; RETROPERITONEAL FAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DIETARY SUPPLEMENT; DISEASE MODEL; FETUS DEVELOPMENT; GENETICS; IMMUNOLOGY; INTRAABDOMINAL FAT; LACTATION; MATERNAL NUTRITION; MENTAL STRESS; METABOLIC SYNDROME X; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZATION; UPREGULATION; WEANING; WISTAR RAT;

RATTUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; DEXAMETHASONE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; FEMALE; FETAL DEVELOPMENT; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; LACTATION; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOM ALLOCATION; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL; UP-REGULATION; WEANING;

EID: 84900559610     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-39     Document Type: Article

References (49)

1. Birdsall KM, Vyas S, Khazaezadeh N, Oteng-Ntim E. Maternal obesity: a review of interventions. Int J Clin Pract 2009, 63:494-507. 10.1111/j.1742-1241.2008.01910.x, 19222635.
2. Thompson NM, Norman AM, Donkin SS, Shankar RR, Vickers MH, Miles JL, Breier BH. Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes. Endocrinology 2007, 148:2345-2354. 10.1210/en.2006-1641, 17272392.
3. Vuguin P, Raab E, Liu B, Barzilai N, Simmons R. Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes 2004, 53:2617-2622. 10.2337/diabetes.53.10.2617, 15448092.
4. Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology 2006, 147:599-606. 10.1210/en.2005-0748, 16210371.
5. Wyrwoll CS, Mark PJ, Mori TA, Waddell BJ. Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3. J Endocrinol 2008, 198:571-579. 10.1677/JOE-08-0210, 18591261.
6. Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR. Changing glucocorticoid action: 11beta-Hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol 2013, 137:82-92. 3925798, 23435016.
7. Burton PJ, Waddell BJ. 11 beta-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J Endocrinol 1994, 143:505-513. 10.1677/joe.0.1430505, 7836896.
8. Smith JT, Waddell BJ. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 2000, 141:2422-2428. 10.1210/endo.141.7.7541, 10875242.
9. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978, 19:65-76.
10. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002, 76:1007-1015.
11. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987, 147:229-263. 10.1111/j.1365-2818.1987.tb02837.x, 3430576.
12. Weibel ER. Stereological Methods: Practical Methods for Biological Morphometry 1979, London - New York - Toronto: Academic Press.
13. Kinosita K, Tsong TY. Survival of sucrose-loaded erythrocytes in the circulation. Nature 1978, 272:258-260. 10.1038/272258a0, 628451.
14. Lareu RR, Harve KS, Raghunath M. Emulating a crowded intracellular environment in vitro dramatically improves RT-PCR performance. Biochem Biophys Res Commun 2007, 363:171-177. 10.1016/j.bbrc.2007.08.156, 17854768.
15. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Totowa: Humana Press, Krawetz S, Misener S.
16. Orly J, Rei Z, Greenberg NM, Richards JS. Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone- induced granulosa cell differentiation: use of reverse transcriptase- polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 1994, 134:2336-2346.
17. Snedecor G, Cochrane W. Statistical Methods 1989, Ames: Iowa State University Press.
18. Breier BH, Vickers MH, Ikenasio BA, Chan KY, Wong WP. Fetal programming of appetite and obesity. Mol Cell Endocrinol 2001, 185:73-79. 10.1016/S0303-7207(01)00634-7, 11738796.
19. Vickers MH, Krechowec SO, Breier BH. Is later obesity programmed in utero?. Curr Drug Targets 2007, 8:923-934. 10.2174/138945007781386857, 17691929.
20. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 2001, 281:E326-E334.
21. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000, 279:E83-E87.
22. Lukaszewski MA, Mayeur S, Fajardy I, Delahaye F, Dutriez-Casteloot I, Montel V, Dickes-Coopman A, Laborie C, Lesage J, Vieau D, Breton C. Maternal prenatal undernutrition programs adipose tissue gene expression in adult male rat offspring under high-fat diet. Am J Physiol Endocrinol Metab 2011, 301:E548-E559. 10.1152/ajpendo.00011.2011, 21712534.
23. Mark PJ, Augustus S, Lewis JL, Hewitt DP, Waddell BJ. Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone. Biol Reprod 2009, 80:1209-1215. 10.1095/biolreprod.108.073650, 2849810, 19208548.
24. Fan C, Zirpoli H, Qi K. n-3 fatty acids modulate adipose tissue inflammation and oxidative stress. Curr Opin Clin Nutr Metab Care 2013, 16:124-132. 10.1097/MCO.0b013e32835c02c8, 23222801.
25. Boullu-Ciocca S, Paulmyer-Lacroix O, Fina F, Ouafik L, Alessi MC, Oliver C, Grino M. Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obes Res 2003, 11:925-929. 10.1038/oby.2003.127, 12917495.
26. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 2004, 101:7088-7093. 10.1073/pnas.0305524101, 406470, 15118095.
27. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001, 142:1371-1376.
28. Burton PJ, Waddell BJ. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod 1999, 60:234-240. 10.1095/biolreprod60.2.234, 9915986.
29. Waddell B, Bollen M, Wyrwoll C, Mori T, Mark P. Developmental programming of adult adrenal structure and steroidogenesis: effects of fetal glucocorticoid excess and postnatal dietary omega-3 fatty acids. J Endocrinol 2010, 205(2):171-178. 10.1677/JOE-09-0459, 20144979.
30. Gnanalingham MG, Mostyn A, Symonds ME, Stephenson T. Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2. Am J Physiol Regul Integr Comp Physiol 2005, 289:R1407-R1415. 10.1152/ajpregu.00375.2005, 16002557.
31. Wyrwoll CS, Mark PJ, Waddell BJ. Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system. Hypertension 2007, 50:579-584. 10.1161/HYPERTENSIONAHA.107.091603, 17664394.
32. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998, 101:2174-2181. 10.1172/JCI1567, 508805, 9593773.
33. Mark PJ, Lewis JL, Jones ML, Keelan JA, Waddell BJ. The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone. Placenta 2013, 34(7):559-566. 10.1016/j.placenta.2013.04.006, 23639575.
34. Sarr O, Yang K, Regnault TR. In utero programming of later adiposity: the role of fetal growth restriction. J Pregnancy 2012, 2012:134758. 3518064, 23251802.
35. Jacobi D, Stanya KJ, Lee CH. Adipose tissue signaling by nuclear receptors in metabolic complications of obesity. Adipocyte 2012, 1:4-12. 10.4161/adip.19036, 3423221,3423221, 22916336.
36. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998, 393:790-793. 10.1038/31701, 9655393.
37. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001, 4:499-502. 10.1097/00075197-200111000-00006, 11706283.
38. Benkalfat NB, Merzouk H, Bouanane S, Merzouk SA, Bellenger J, Gresti J, Tessier C, Narce M. Altered adipose tissue metabolism in offspring of dietary obese rat dams. Clin Sci (Lond) 2011, 121:19-28. 10.1042/CS20100534, 21288203.
39. Evans RD, Williamson DH. Comparison of effects of platelet-activating factor and tumour necrosis factor-alpha on lipid metabolism in adrenalectomized rats in vivo. Biochim Biophys Acta 1991, 1086:191-196. 10.1016/0005-2760(91)90007-5, 1932101.
40. Plomgaard P, Fischer CP, Ibfelt T, Pedersen BK, van Hall G. Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab 2008, 93:543-549. 10.1210/jc.2007-1761, 18029463.
41. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65:1645S-1654S.
42. Rustan AC, Nossen JO, Christiansen EN, Drevon CA. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res 1988, 29:1417-1426.
43. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem 2007, 55:7170-7176. 10.1021/jf071225x, 17661494.
44. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003, 113:159-170. 10.1016/S0092-8674(03)00269-1, 12705865.
45. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) 2009, 116:1-16. 10.1042/CS20070456, 19037880.
46. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
47. Lonn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2009, 24(1):326-331.
48. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006, 20:1540-1542. 10.1096/fj.05-5678fje, 16754744.
49. Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G, Karádi I, Sikter M, Kaszás E, Dworak O, Gerö G, Cseh K. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 2003, 149:129-135. 10.1530/eje.0.1490129, 12887290.